查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828132

2025年全球植入式心臟整流去颤器市场报告

Implantable Defibrillators Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，植入式心臟整流去颤器市场稳定成长，预计2024年将达55.4亿美元，2025年将达56.9亿美元，复合年增长率为2.8%。预测期内的成长归因于心臟病盛行率的上升、临床证据和研究、人口老化、认知和教育的提高以及合作与伙伴关係的加强。

植入式心臟整流去颤器市场预计将在未来几年强劲成长，到2029年将达到72.3亿美元，年复合成长率（CAGR）为6.1%。预测期内的成长可归因于远端监控与远端医疗的整合、适应症的不断扩大、对心臟衰竭管理的日益重视、个人化医疗方法以及全球医疗保健基础设施的扩展。预测期内的主要趋势包括小型化和设计创新、远端监控和连接、个人化治疗方法、无导线植入式心臟整流去颤器以及电池技术的进步。

植入式心臟整流去颤器是一种小型电池供电装置，植入胸腔后用于调节异常心律。它持续监测心律，并在检测到危险或不规则的模式时发出电击以恢復正常心律。

植入式心臟整流去颤器的主要类型包括单植入式心臟整流去颤器、植入式心臟整流去颤器和双心室植入式心臟整流去颤器。植入式心臟整流去颤器仅将一个右心室ICD电击线圈导线植入心臟右心室。这些设备持续监测患者的心率和心律，并可对心臟施加电击。主要的植入方式是经静脉和皮下，医院、诊所、门诊手术中心和其他终端使用者均采用此方法。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供植入式心臟整流去颤器的市场统计数据，例如全球市场规模、各地区市场份额、竞争对手的植入式心臟整流去颤器份额、详细的植入式心臟整流去颤器植入式心臟整流去颤器市场、市场趋势和商机，以及在植入式心臟整流去颤器行业取得成功所需的数据。植入式心臟整流去颤器市场研究报告提供了全面的展望，并对产业现状和未来进行了详细分析。

我们预测未来五年该市场将成长6.1%，较我们先前对该市场的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自日本和瑞典等主要地区的高压电容器和钛合金外壳征收关税直接影响美国，从而导致救生心臟设备的供应减少，以及心臟麻痹预防设备价格上涨。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

心臟麻痹盛行率预计将上升，这将推动植入式心臟整流去颤器市场的成长。心臟麻痹(SCA) 是指心臟意外停止跳动的一种疾病，而植入式心臟整流去颤器透过检测和纠正可能导致 SCA 的异常心律，在提供挽救生命的治疗方面发挥着至关重要的作用。根据《美国心臟病学会杂誌》报道，SCD 每年在美国导致 18.5 万至 45 万人死亡，占所有死亡人数的 7% 至 18%。因此，心臟麻痹盛行率的上升是推动植入式心臟整流去颤器市场成长的关键因素。

预计糖尿病盛行率的上升将推动未来植入式心臟整流去颤器市场的扩张。糖尿病是一种以高血糖值为特征的慢性代谢性疾病，随着时间的推移，会对心臟、血管、眼睛、肾臟和神经造成严重损害。植入式心臟整流去颤器(ICD) 对于管理糖尿病患者至关重要，尤其是那些有心臟猝死风险的患者。研究表明，ICD 可有效降低包括糖尿病患者在内的严重心肌功能障碍患者的心律不整死亡率和总死亡率。例如，2024 年 6 月，英国管理机构 NHS England 报告称，2023 年在 GP 註册的患者有 3,615,330 名被诊断为非糖尿病性高血糖症，也称为糖尿病前期。因此，糖尿病盛行率的上升正在推动植入式心臟整流去颤器市场的成长。

植入式心臟整流去颤器市场的一个显着趋势是各大公司都注重产品创新。这些公司正专注于开发新产品以保持竞争力。例如，2023 年 12 月，总部位于爱尔兰的医疗设备公司Medtronic宣布推出一种新型植入式心臟整流去颤器，称为 Aurora 血管外 ICD。与传统的经静脉 ICD 不同，该装置插入左腋下皮下，在心臟麻痹和持续起搏器治疗期间提供去心房颤动。它使用 Epsila 导线，以微创方式连接到胸骨下方的心臟。此外，该植入还采用了Medtronic的 SmartSense 技术（旨在降低不必要电击的风险）和 SureScan 技术（让患者在配戴装置时可以进行 MRI 扫描）。

植入式心臟整流去颤器市场的主要企业也专注于推出具有尖端功能的先进心律管理 (CRM) 设备，以推动市场收益。这些配备创新技术的设备可以有效监测和管理心臟问题。例如，2023 年 10 月，总部位于法国的心臟节律器和植入式心律去心房颤动开发商和製造商 MicroPort CRM 在日本推出了 ULYS植入式心臟整流去颤器(ICD) 和 INVICTA去心房颤动导线。由于最尖端科技和低电流消耗，ULYS ICD 的使用寿命预计将比传统 ICD 长得多。 INVICTA去心房颤动颤导线旨在持续检测来自心臟右心室的电讯号，并在发生可能致命的心室心搏过速时发出去心房颤动电击或起搏治疗。

2022年12月，美国医疗保健产品製造商强生医疗以166亿美元收购了Abiomed。这项策略性措施使强生能够透过整合Abiomed的心臟恢復技术，增强其全球领先的Biosense Webster电生理业务，并扩大其在快速增长的循环系统领域的产品组合，其中包括植入式心臟整流去颤器。 Abiomed是美国的循环系统医疗技术供应商，专门治疗心臟衰竭和冠状动脉疾病。

植入式心臟整流去颤器市场的主要企业包括波士顿科学公司、LivaNova PLC、BIoTronik SE & Co KG、微创医疗科学公司、美敦力公司、圣犹达医疗公司、雅培实验室、Sorin Group Italia Srl、日本光电公司、荷兰皇家飞利浦公司、福田电株式会社. Corporation、Defibtech LLC、HeartSine Technologies LLC、Schiller AG、CU Medical Systems Inc.、迈瑞医疗国际有限公司、深圳迈瑞生物医疗电子股份有限公司、北京迈瑞生物医疗电子有限公司、Bexen Cardio SL、Pacemaker Technologies 和 EBR Systems Inc.。

2024年，北美是植入式心臟整流去颤器市场最大的地区。预计亚太地区将成为全球植入式心臟整流去颤器市场预测期内成长最快的地区。植入式心臟整流去颤器市场报告涵盖亚太地区、西欧、东欧、北美、南美以及中东和非洲。

植入式心臟整流去颤器市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、美国、英国、加拿大、义大利、西班牙

植入式心臟整流去颤器市场包括心外膜植入式心臟整流去颤器、胸骨下植入式心臟整流去颤器以及带心房感应的单腔ICD的销售。此市场的价值是指“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球植入式心臟整流去颤器：PESTEL 分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球植入式心臟整流去颤器市场：成长率分析
  • 全球植入式心臟整流去颤器市场表现：规模与成长，2019-2024
  • 全球植入式心臟整流去颤器市场预测：规模与成长，2024-2029年，2034年
  • 全球植入式心臟整流去颤器：总目标市场（TAM）

第六章 市场细分

  • 全球植入式心臟整流去颤器市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 单植入式心臟整流去颤器
  • 双腔植入式心臟整流去颤器
  • 双心室植入式心臟整流去颤器
  • 全球植入式心臟整流去颤器市场（按手术类型、性能和预测）2019-2024 年、2024-2029 年、2034 年
  • 经静脉植入式心臟整流去颤器
  • 皮下植入式心臟整流去颤器
  • 全球植入式心臟整流去颤器市场（依最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 门诊手术中心
  • 其他的
  • 全球植入式心臟整流去颤器市场：单植入式心臟整流去颤器细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 标准单腔ICD
  • 无导线单腔ICD
  • 全球植入式心臟整流去颤器市场：双腔植入式心臟整流去颤器细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 标准胆管 ICD
  • 先进的胆管 ICD
  • 全球植入式心臟整流去颤器市场：双心室植入式心臟整流去颤器细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 标准双心室ICD
  • 先进的双心室 ICD 及 CRT

第七章 区域和国家分析

  • 全球植入式心臟整流去颤器市场：按地区、绩效及预测，2019-2024年、2024-2029年、2034年
  • 全球植入式心臟整流去颤器市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 植入式心臟整流去颤器市场：竞争格局
  • 植入式心臟整流去颤器市场：公司简介
    • Boston Scientific Corporation
    • LivaNova PLC
    • BIoTronik SE & Co KG
    • MicroPort Scientific Corporation
    • Medtronic plc

第31章：其他领先和创新企业

  • St. Jude Medical Inc.
  • Abbott Laboratories
  • Sorin Group Italia Srl
  • Nihon Kohden Corporation
  • Koninklijke Philips NV
  • Fukuda Denshi Co Ltd.
  • Progetti Srl
  • Imricor Medical Systems Inc.
  • ZOLL Medical Corporation
  • Physio-Control International Inc.
  • Cardiac Science Corporation
  • Defibtech LLC
  • HeartSine Technologies LLC
  • Schiller AG
  • CU Medical Systems Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年植入式心臟整流去颤器市场：提供新机会的国家
  • 2029年植入式心臟整流去颤器市场：细分市场带来新机会
  • 2029年植入式心臟整流去颤器市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24223u

An implantable defibrillator is a small, battery-operated device inserted into the chest to regulate abnormal heart rhythms. It continuously monitors the heart's rhythm, and if it detects a dangerous or irregular pattern, it delivers an electrical shock to restore a normal rhythm.

The primary types of implantable defibrillators include single-chambered implantable defibrillators, dual-chambered implantable defibrillators, and biventricular implantable defibrillators. Single-chamber implantable defibrillators have only one right ventricular ICD shocking coil lead placed inside the heart's right ventricle. These devices continuously monitor the patient's heart rate and rhythm and can deliver electrical shocks to the heart. The main procedures for implantation are trans-venous implantable defibrillators and subcutaneous implantable defibrillators, utilized by hospitals and clinics, ambulatory surgery centers, and other end-users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The implantable defibrillators market research report is one of a series of new reports from The Business Research Company that provides implantable defibrillators market statistics, including implantable defibrillators industry global market size, regional shares, competitors with an implantable defibrillators market share, detailed implantable defibrillators market segments, market trends and opportunities, and any further data you may need to thrive in the implantable defibrillators industry. The implantable defibrillators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable defibrillators market size has grown steadily in recent years. It will grow from $5.54 billion in 2024 to $5.69 billion in 2025 at a compound annual growth rate (CAGR) of 2.8%. The growth in the historic period can be attributed to the increased prevalence of cardiac disorders, clinical evidence and research, rise in the aging population, increased awareness and education, collaborations and partnerships.

The implantable defibrillators market size is expected to see strong growth in the next few years. It will grow to $7.23 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to remote monitoring and telemedicine integration, expansion of indications, focus on heart failure management, personalized medicine approaches, and global expansion of healthcare infrastructure. Major trends in the forecast period include miniaturization and design innovations, remote monitoring and connectivity, personalized therapy approaches, leadless implantable defibrillators, and battery technology advancements.

The forecast of 6.1% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on high-voltage capacitors and titanium alloy housings, sourced from key regions such as Japan and Sweden, which could lead to reduced availability of life-saving cardiac devices and higher prices for sudden cardiac arrest prevention.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expected rise in the prevalence of sudden cardiac arrest is poised to drive the growth of the implantable defibrillators market. Sudden cardiac arrest (SCA) is a condition where the heart unexpectedly stops beating, and implantable defibrillators play a vital role in providing lifesaving therapy by detecting and correcting abnormal heart rhythms that may lead to SCA. According to a report by the Journal of the American College of Cardiology, SCD causes 185,000 to 450,000 deaths annually in the US population, accounting for 7% to 18% of all fatalities. Therefore, the increasing prevalence of sudden cardiac arrest is a significant factor propelling the growth of the implantable defibrillators market.

The rising incidence of diabetes is anticipated to drive the expansion of the implantable defibrillators market in the future. Diabetes is a chronic metabolic condition characterized by high blood glucose or sugar levels, which can lead to significant damage to the heart, blood vessels, eyes, kidneys, and nerves over time. Implantable cardioverter defibrillators (ICDs) are vital for managing patients with diabetes, especially those who are at risk of sudden cardiac death. Research has demonstrated that ICDs can effectively lower the rates of arrhythmic death and overall mortality in patients with severe myocardial dysfunction, including those with diabetes. For example, in June 2024, NHS England, a governing body in the UK, reported that in 2023, 3,615,330 individuals registered with a GP were diagnosed with non-diabetic hyperglycemia, also known as pre-diabetes, which represents an increase from 3,065,825 in 2022-an approximate rise of 18%. Consequently, the growing prevalence of diabetes is fueling the growth of the implantable defibrillators market.

A noteworthy trend in the implantable defibrillators market is the emphasis on product innovations by major companies. These companies are focusing on developing new products to maintain their competitive edge. For example, in December 2023, Medtronic, an Ireland-based medical device company, introduced a novel type of implantable cardioverter-defibrillator called the Aurora extravascular ICD. Unsuch as traditional transvenous ICDs, this device is inserted under the skin beneath the left armpit, providing defibrillation during cardiac arrest and ongoing pacemaker therapies. It features Epsila leads that are minimally invasively connected to the heart beneath the breastbone. Additionally, the implant incorporates Medtronic's Smart Sense technology, aimed at reducing the risk of unwarranted shocks, and SureScan technology, allowing patients to undergo MRI tests with the device in place.

Major companies operating in the implantable defibrillators market are also focused on introducing advanced Cardiac Rhythm Management (CRM) devices with cutting-edge features to drive market revenues. These devices, equipped with innovative technology, monitor and manage cardiac issues effectively. For instance, in October 2023, MicroPort CRM, a France-based developer and manufacturer of cardiac pacemakers and implantable cardiac defibrillators, launched the ULYS Implantable Cardioverter Defibrillator (ICDs) and the INVICTA defibrillation lead in Japan. The ULYS ICD, with its cutting-edge technology and low current consumption, is expected to have a significantly longer lifespan than conventional ICD devices. The INVICTA defibrillation lead, designed to continuously detect electrical signals from the heart's right ventricle, provides defibrillation shocks or pacing therapy in the case of a potentially fatal ventricular tachyarrhythmia.

In December 2022, Johnson & Johnson Services Inc., a US-based healthcare product manufacturer, completed the acquisition of Abiomed for $16.6 billion. This strategic move allowed Johnson & Johnson to enhance its global market-leading Biosense Webster electrophysiology business by adding heart recovery technologies from Abiomed, expanding its portfolio in rapidly growing cardiovascular areas, including implantable defibrillators. Abiomed is a US-based provider of cardiovascular medical technology specializing in treating heart failure and coronary artery disease.

Major companies operating in the implantable defibrillators market include Boston Scientific Corporation, LivaNova PLC, Biotronik SE & Co KG, MicroPort Scientific Corporation, Medtronic plc, St. Jude Medical Inc., Abbott Laboratories, Sorin Group Italia S.r.l., Nihon Kohden Corporation, Koninklijke Philips N.V., Fukuda Denshi Co Ltd., Progetti S.r.l., Imricor Medical Systems Inc., ZOLL Medical Corporation, Physio-Control International Inc., Cardiac Science Corporation, Defibtech LLC, HeartSine Technologies LLC, Schiller AG, CU Medical Systems Inc., Mindray Medical International Limited, Shenzhen Mindray Bio-Medical Electronics Co Ltd., Beijing M&B Electronic Instruments Co Ltd., Bexen Cardio SL, Pacemaker Technologies, EBR Systems Inc.

North America was the largest region in the implantable defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global implanted defibrillator market forecast period. The regions covered in the implantable defibrillators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the implantable defibrillators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable defibrillator market consists of sales of epicardial implantable cardioverter-defibrillator, substernal implantable cardioverter-defibrillator, and single-chamber ICD with atrial sensing. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Defibrillators Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable defibrillators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable defibrillators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable defibrillators market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Single Chambered Implantable Defibrillators; Dual Chambered Implantable Defibrillators; Biventricular Implantable Defibrillators
  • 2) By Procedure Type: Trans-Venous Implantable Defibrillators; Subcutaneous Implantable Defibrillators
  • 3) By End User: Hospitals And Clinics; Ambulatory Surgery Centers; Other End Users
  • Subsegments:
  • 1) By Single Chambered Implantable Defibrillators: Standard Single Chamber ICDs; Leadless Single Chamber ICDs
  • 2) By Dual Chambered Implantable Defibrillators: Standard Dual Chamber ICDs; Advanced Dual Chamber ICDs
  • 3) By Biventricular Implantable Defibrillators: Standard Biventricular ICDs; Advanced Biventricular ICDs With CRT
  • Companies Mentioned: Boston Scientific Corporation; LivaNova PLC; Biotronik SE & Co KG; MicroPort Scientific Corporation; Medtronic plc; St. Jude Medical Inc.; Abbott Laboratories; Sorin Group Italia S.r.l.; Nihon Kohden Corporation; Koninklijke Philips N.V.; Fukuda Denshi Co Ltd.; Progetti S.r.l.; Imricor Medical Systems Inc.; ZOLL Medical Corporation; Physio-Control International Inc.; Cardiac Science Corporation; Defibtech LLC; HeartSine Technologies LLC; Schiller AG; CU Medical Systems Inc.; Mindray Medical International Limited; Shenzhen Mindray Bio-Medical Electronics Co Ltd.; Beijing M&B Electronic Instruments Co Ltd.; Bexen Cardio SL; Pacemaker Technologies; EBR Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Defibrillators Market Characteristics

3. Implantable Defibrillators Market Trends And Strategies

4. Implantable Defibrillators Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Implantable Defibrillators Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Defibrillators PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Defibrillators Market Growth Rate Analysis
  • 5.4. Global Implantable Defibrillators Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Defibrillators Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Defibrillators Total Addressable Market (TAM)

6. Implantable Defibrillators Market Segmentation

  • 6.1. Global Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Chambered Implantable Defibrillators
  • Dual Chambered Implantable Defibrillators
  • Biventricular Implantable Defibrillators
  • 6.2. Global Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Trans-Venous Implantable Defibrillators
  • Subcutaneous Implantable Defibrillators
  • 6.3. Global Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Surgery Centers
  • Other End Users
  • 6.4. Global Implantable Defibrillators Market, Sub-Segmentation Of Single Chambered Implantable Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Single Chamber ICDs
  • Leadless Single Chamber ICDs
  • 6.5. Global Implantable Defibrillators Market, Sub-Segmentation Of Dual Chambered Implantable Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Dual Chamber ICDs
  • Advanced Dual Chamber ICDs
  • 6.6. Global Implantable Defibrillators Market, Sub-Segmentation Of Biventricular Implantable Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Biventricular ICDs
  • Advanced Biventricular ICDs With CRT

7. Implantable Defibrillators Market Regional And Country Analysis

  • 7.1. Global Implantable Defibrillators Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Defibrillators Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Defibrillators Market

  • 8.1. Asia-Pacific Implantable Defibrillators Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Defibrillators Market

  • 9.1. China Implantable Defibrillators Market Overview
  • 9.2. China Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Defibrillators Market

  • 10.1. India Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Defibrillators Market

  • 11.1. Japan Implantable Defibrillators Market Overview
  • 11.2. Japan Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Defibrillators Market

  • 12.1. Australia Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Defibrillators Market

  • 13.1. Indonesia Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Defibrillators Market

  • 14.1. South Korea Implantable Defibrillators Market Overview
  • 14.2. South Korea Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Defibrillators Market

  • 15.1. Western Europe Implantable Defibrillators Market Overview
  • 15.2. Western Europe Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Defibrillators Market

  • 16.1. UK Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Defibrillators Market

  • 17.1. Germany Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Defibrillators Market

  • 18.1. France Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Defibrillators Market

  • 19.1. Italy Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Defibrillators Market

  • 20.1. Spain Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Defibrillators Market

  • 21.1. Eastern Europe Implantable Defibrillators Market Overview
  • 21.2. Eastern Europe Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Defibrillators Market

  • 22.1. Russia Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Defibrillators Market

  • 23.1. North America Implantable Defibrillators Market Overview
  • 23.2. North America Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Defibrillators Market

  • 24.1. USA Implantable Defibrillators Market Overview
  • 24.2. USA Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Defibrillators Market

  • 25.1. Canada Implantable Defibrillators Market Overview
  • 25.2. Canada Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Defibrillators Market

  • 26.1. South America Implantable Defibrillators Market Overview
  • 26.2. South America Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Defibrillators Market

  • 27.1. Brazil Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Defibrillators Market

  • 28.1. Middle East Implantable Defibrillators Market Overview
  • 28.2. Middle East Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Defibrillators Market

  • 29.1. Africa Implantable Defibrillators Market Overview
  • 29.2. Africa Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Defibrillators Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Defibrillators Market Competitive Landscape
  • 30.2. Implantable Defibrillators Market Company Profiles
    • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Biotronik SE & Co KG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. MicroPort Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Defibrillators Market Other Major And Innovative Companies

  • 31.1. St. Jude Medical Inc.
  • 31.2. Abbott Laboratories
  • 31.3. Sorin Group Italia S.r.l.
  • 31.4. Nihon Kohden Corporation
  • 31.5. Koninklijke Philips N.V.
  • 31.6. Fukuda Denshi Co Ltd.
  • 31.7. Progetti S.r.l.
  • 31.8. Imricor Medical Systems Inc.
  • 31.9. ZOLL Medical Corporation
  • 31.10. Physio-Control International Inc.
  • 31.11. Cardiac Science Corporation
  • 31.12. Defibtech LLC
  • 31.13. HeartSine Technologies LLC
  • 31.14. Schiller AG
  • 31.15. CU Medical Systems Inc.

32. Global Implantable Defibrillators Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Defibrillators Market

34. Recent Developments In The Implantable Defibrillators Market

35. Implantable Defibrillators Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Defibrillators Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Defibrillators Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Defibrillators Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer